Series A Rounds H1 2014: Fewer Deals, Comparable Money
This article was originally published in Start Up
Executive Summary
The money raised in Series A financings for biopharma, medtech, and diagnostics start-ups is down 8% from the same period last year, but the number of deals is down even more dramatically.